性感染症（STD）治療薬の世界市場（～2026年）

• 英文タイトル：Global Sexually Transmitted Disease (STD ) Drug Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY09405
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、115ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は性感染症（STD）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗生物質、抗ウイルス剤、ワクチン）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別性感染症（STD）治療薬の競争状況、市場シェア
・世界の性感染症（STD）治療薬市場：種類別市場規模 2015年-2020年（抗生物質、抗ウイルス剤、ワクチン）
・世界の性感染症（STD）治療薬市場：種類別市場規模予測 2021年-2026年（抗生物質、抗ウイルス剤、ワクチン）
・世界の性感染症（STD）治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック）
・世界の性感染症（STD）治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック）
・北米の性感染症（STD）治療薬市場分析：米国、カナダ
・ヨーロッパの性感染症（STD）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの性感染症（STD）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の性感染症（STD）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの性感染症（STD）治療薬市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Roche、Bayer、Eli Lilly、Johnson & Johnson、Bristol-Myers Squibb、AbbVie、Gilead Sciences、GlaxoSmithKline、Merck
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Sexually Transmitted Disease (STD ) Drug Market
The global Sexually Transmitted Disease (STD ) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Sexually Transmitted Disease (STD ) Drug Scope and Market Size
Sexually Transmitted Disease (STD ) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sexually Transmitted Disease (STD ) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Sexually Transmitted Disease (STD ) Drug market is segmented into
Antibiotics
Antiviral
Vaccines

Segment by Application, the Sexually Transmitted Disease (STD ) Drug market is segmented into
Hospital
Clinic

Regional and Country-level Analysis
The Sexually Transmitted Disease (STD ) Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sexually Transmitted Disease (STD ) Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Sexually Transmitted Disease (STD ) Drug Market Share Analysis
Sexually Transmitted Disease (STD ) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sexually Transmitted Disease (STD ) Drug business, the date to enter into the Sexually Transmitted Disease (STD ) Drug market, Sexually Transmitted Disease (STD ) Drug product introduction, recent developments, etc.

The major vendors covered:
Pfizer
Roche
Bayer
Eli Lilly
Johnson & Johnson
Bristol-Myers Squibb
AbbVie
Gilead Sciences
GlaxoSmithKline
Merck

レポート目次

1 Study Coverage
1.1 Sexually Transmitted Disease (STD ) Drug Product Introduction
1.2 Market Segments
1.3 Key Sexually Transmitted Disease (STD ) Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Type
1.4.2 Antibiotics
1.4.3 Antiviral
1.4.4 Vaccines
1.5 Market by Application
1.5.1 Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Sexually Transmitted Disease (STD ) Drug Market Size, Estimates and Forecasts
2.1.1 Global Sexually Transmitted Disease (STD ) Drug Revenue 2015-2026
2.1.2 Global Sexually Transmitted Disease (STD ) Drug Sales 2015-2026
2.2 Global Sexually Transmitted Disease (STD ) Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Sexually Transmitted Disease (STD ) Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sexually Transmitted Disease (STD ) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Sexually Transmitted Disease (STD ) Drug Competitor Landscape by Players
3.1 Sexually Transmitted Disease (STD ) Drug Sales by Manufacturers
3.1.1 Sexually Transmitted Disease (STD ) Drug Sales by Manufacturers (2015-2020)
3.1.2 Sexually Transmitted Disease (STD ) Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Sexually Transmitted Disease (STD ) Drug Revenue by Manufacturers
3.2.1 Sexually Transmitted Disease (STD ) Drug Revenue by Manufacturers (2015-2020)
3.2.2 Sexually Transmitted Disease (STD ) Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sexually Transmitted Disease (STD ) Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sexually Transmitted Disease (STD ) Drug Revenue in 2019
3.2.5 Global Sexually Transmitted Disease (STD ) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sexually Transmitted Disease (STD ) Drug Price by Manufacturers
3.4 Sexually Transmitted Disease (STD ) Drug Manufacturing Base Distribution, Product Types
3.4.1 Sexually Transmitted Disease (STD ) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sexually Transmitted Disease (STD ) Drug Product Type
3.4.3 Date of International Manufacturers Enter into Sexually Transmitted Disease (STD ) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Sexually Transmitted Disease (STD ) Drug Market Size by Type (2015-2020)
4.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020)
4.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue by Type (2015-2020)
4.1.3 Sexually Transmitted Disease (STD ) Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Type (2021-2026)
4.2.3 Sexually Transmitted Disease (STD ) Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sexually Transmitted Disease (STD ) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Sexually Transmitted Disease (STD ) Drug Market Size by Application (2015-2020)
5.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020)
5.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue by Application (2015-2020)
5.1.3 Sexually Transmitted Disease (STD ) Drug Price by Application (2015-2020)
5.2 Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Sexually Transmitted Disease (STD ) Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Sexually Transmitted Disease (STD ) Drug by Country
6.1.1 North America Sexually Transmitted Disease (STD ) Drug Sales by Country
6.1.2 North America Sexually Transmitted Disease (STD ) Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type
6.3 North America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Sexually Transmitted Disease (STD ) Drug by Country
7.1.1 Europe Sexually Transmitted Disease (STD ) Drug Sales by Country
7.1.2 Europe Sexually Transmitted Disease (STD ) Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type
7.3 Europe Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Sexually Transmitted Disease (STD ) Drug by Region
8.1.1 Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Region
8.1.2 Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type
8.3 Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Sexually Transmitted Disease (STD ) Drug by Country
9.1.1 Latin America Sexually Transmitted Disease (STD ) Drug Sales by Country
9.1.2 Latin America Sexually Transmitted Disease (STD ) Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type
9.3 Central & South America Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Sexually Transmitted Disease (STD ) Drug by Country
10.1.1 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Country
10.1.2 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Type
10.3 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Sexually Transmitted Disease (STD ) Drug Products Offered
11.1.5 Pfizer Related Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Description and Business Overview
11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roche Sexually Transmitted Disease (STD ) Drug Products Offered
11.2.5 Roche Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Sexually Transmitted Disease (STD ) Drug Products Offered
11.3.5 Bayer Related Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Description and Business Overview
11.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly Sexually Transmitted Disease (STD ) Drug Products Offered
11.4.5 Eli Lilly Related Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description and Business Overview
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Products Offered
11.5.5 Johnson & Johnson Related Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description and Business Overview
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Products Offered
11.6.5 Bristol-Myers Squibb Related Developments
11.7 AbbVie
11.7.1 AbbVie Corporation Information
11.7.2 AbbVie Description and Business Overview
11.7.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AbbVie Sexually Transmitted Disease (STD ) Drug Products Offered
11.7.5 AbbVie Related Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Corporation Information
11.8.2 Gilead Sciences Description and Business Overview
11.8.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Gilead Sciences Sexually Transmitted Disease (STD ) Drug Products Offered
11.8.5 Gilead Sciences Related Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Description and Business Overview
11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Products Offered
11.9.5 GlaxoSmithKline Related Developments
11.10 Merck
11.10.1 Merck Corporation Information
11.10.2 Merck Description and Business Overview
11.10.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Merck Sexually Transmitted Disease (STD ) Drug Products Offered
11.10.5 Merck Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Sexually Transmitted Disease (STD ) Drug Products Offered
11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Sexually Transmitted Disease (STD ) Drug Market Estimates and Projections by Region
12.1.1 Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Regions 2021-2026
12.2 North America Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)
12.2.1 North America: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)
12.2.2 North America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)
12.2.3 North America: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)
12.3.2 Europe: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sexually Transmitted Disease (STD ) Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sexually Transmitted Disease (STD ) Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Sexually Transmitted Disease (STD ) Drug Market Segments
Table 2. Ranking of Global Top Sexually Transmitted Disease (STD ) Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antibiotics
Table 5. Major Manufacturers of Antiviral
Table 6. Major Manufacturers of Vaccines
Table 7. Global Sexually Transmitted Disease (STD ) Drug Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Sexually Transmitted Disease (STD ) Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Sexually Transmitted Disease (STD ) Drug Sales by Regions 2015-2020 (K Units)
Table 10. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Sexually Transmitted Disease (STD ) Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Sexually Transmitted Disease (STD ) Drug Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Sexually Transmitted Disease (STD ) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Sexually Transmitted Disease (STD ) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sexually Transmitted Disease (STD ) Drug as of 2019)
Table 16. Sexually Transmitted Disease (STD ) Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Sexually Transmitted Disease (STD ) Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Sexually Transmitted Disease (STD ) Drug Price (2015-2020) (US$/Unit)
Table 19. Sexually Transmitted Disease (STD ) Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Sexually Transmitted Disease (STD ) Drug Product Type
Table 21. Date of International Manufacturers Enter into Sexually Transmitted Disease (STD ) Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)
Table 24. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Type (2015-2020)
Table 25. Global Sexually Transmitted Disease (STD ) Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Sexually Transmitted Disease (STD ) Drug Revenue Share by Type (2015-2020)
Table 27. Sexually Transmitted Disease (STD ) Drug Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 28. Global Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)
Table 29. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Application (2015-2020)
Table 30. North America Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)
Table 31. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)
Table 32. North America Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)
Table 34. North America Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)
Table 35. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)
Table 36. North America Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)
Table 37. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)
Table 38. Europe Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)
Table 39. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)
Table 40. Europe Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)
Table 42. Europe Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)
Table 43. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)
Table 44. Europe Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)
Table 45. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)
Table 54. Latin America Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)
Table 55. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)
Table 58. Latin America Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)
Table 59. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)
Table 60. Latin America Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)
Table 61. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Major Businesses
Table 72. Pfizer Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer Product
Table 74. Pfizer Recent Development
Table 75. Roche Corporation Information
Table 76. Roche Description and Major Businesses
Table 77. Roche Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Roche Product
Table 79. Roche Recent Development
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Major Businesses
Table 82. Bayer Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. Bayer Product
Table 84. Bayer Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Major Businesses
Table 87. Eli Lilly Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 88. Eli Lilly Product
Table 89. Eli Lilly Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Major Businesses
Table 92. Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Recent Development
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Major Businesses
Table 97. Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Product
Table 99. Bristol-Myers Squibb Recent Development
Table 100. AbbVie Corporation Information
Table 101. AbbVie Description and Major Businesses
Table 102. AbbVie Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 103. AbbVie Product
Table 104. AbbVie Recent Development
Table 105. Gilead Sciences Corporation Information
Table 106. Gilead Sciences Description and Major Businesses
Table 107. Gilead Sciences Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 108. Gilead Sciences Product
Table 109. Gilead Sciences Recent Development
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Major Businesses
Table 112. GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 113. GlaxoSmithKline Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Major Businesses
Table 117. Merck Sexually Transmitted Disease (STD ) Drug Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 118. Merck Product
Table 119. Merck Recent Development
Table 120. Global Sexually Transmitted Disease (STD ) Drug Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Sexually Transmitted Disease (STD ) Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Sexually Transmitted Disease (STD ) Drug Players
Table 138. Sexually Transmitted Disease (STD ) Drug Customers List
Table 139. Sexually Transmitted Disease (STD ) Drug Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Sexually Transmitted Disease (STD ) Drug Product Picture
Figure 2. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Antibiotics Product Picture
Figure 4. Antiviral Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Sexually Transmitted Disease (STD ) Drug Report Years Considered
Figure 10. Global Sexually Transmitted Disease (STD ) Drug Market Size 2015-2026 (US$ Million)
Figure 11. Global Sexually Transmitted Disease (STD ) Drug Sales 2015-2026 (K Units)
Figure 12. Global Sexually Transmitted Disease (STD ) Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region (2015-2020)
Figure 14. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region in 2019
Figure 15. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region (2015-2020)
Figure 16. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region in 2019
Figure 17. Global Sexually Transmitted Disease (STD ) Drug Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Sexually Transmitted Disease (STD ) Drug Revenue in 2019
Figure 19. Sexually Transmitted Disease (STD ) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type (2015-2020)
Figure 21. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Type in 2019
Figure 22. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Type (2015-2020)
Figure 23. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Type in 2019
Figure 24. Global Sexually Transmitted Disease (STD ) Drug Market Share by Price Range (2015-2020)
Figure 25. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application (2015-2020)
Figure 26. Global Sexually Transmitted Disease (STD ) Drug Sales Market Share by Application in 2019
Figure 27. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Application (2015-2020)
Figure 28. Global Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Application in 2019
Figure 29. North America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019
Figure 32. North America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019
Figure 33. U.S. Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019
Figure 38. North America Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019
Figure 39. Europe Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019
Figure 42. Europe Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019
Figure 43. Germany Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019
Figure 54. Europe Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019
Figure 55. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Market Share by Region in 2019
Figure 58. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Region in 2019
Figure 59. China Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019
Figure 82. Asia Pacific Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019
Figure 83. Latin America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019
Figure 86. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019
Figure 87. Mexico Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019
Figure 94. Latin America Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019
Figure 95. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Market Share by Country in 2019
Figure 99. Turkey Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Sexually Transmitted Disease (STD ) Drug Sales Growth Rate (2015-2020) (K Units)
Figure 104. UAE Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Share by Type in 2019
Figure 106. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Market Share by Application in 2019
Figure 107. North America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Sexually Transmitted Disease (STD ) Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

以下、関連資料のご紹介

性感染症（STD）診断の世界市場（～2026年）

Global Sexually Transmitted Disease (STD) Diagnosis Market Size, Status and Forecast 2020-2026
MRC2-11QY04597 2020年11月20日 127Pages
当調査資料は性感染症（STD）診断のグローバル市場について調査・分析したレポートです。種類別（クラミジア検査、梅毒検査、淋病検査、単純ヘルペスウイルス検査、ヒトパピローマウイルス検査、ヒト免疫不全ウイルス検査）市場規模、用途別（政府機関、病院、診断クリニック）市場規模、地域別（北米、米国、カナダ、ヨ...

胃食道逆流症（GERD）治療薬の世界市場（～2026年）

Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12006 2020年11月25日 98Pages
当調査資料は胃食道逆流症（GERD）治療薬のグローバル市場について調査・分析したレポートです。種類別（制酸剤、運動促進薬、H2受容体遮断薬、プロトンポンプ阻害薬（PPI））市場規模、用途別（胸やけ、酸逆流症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

フォンウィルブランド病（VWD）治療薬の世界市場（～2026年）

Global Von Willebrand Disease (VWD) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY05054 2020年11月20日 92Pages
当調査資料はフォンウィルブランド病（VWD）治療薬のグローバル市場について調査・分析したレポートです。種類別（デスモプレシン、血栓安定化薬、線維素溶解阻害剤、補充療法、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

末梢動脈疾患（PAD）治療薬の世界市場（～2026年）

Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04221 2020年11月20日 94Pages
当調査資料は末梢動脈疾患（PAD）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗血小板薬、二重抗血小板療法薬、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国...

深部静脈血栓症（DVT）治療薬の世界市場（～2026年）

Global Deep Vein Thrombosis (DVT) Drug Market Size, Status and Forecast 2020-2026
MRC2-11QY11584 2020年11月25日 97Pages
当調査資料は深部静脈血栓症（DVT）治療薬のグローバル市場について調査・分析したレポートです。種類別（抗凝血剤、組織プラスミノーゲン活性化因子、その他薬剤）市場規模、用途別（病院、クリニック、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

末期腎疾患（ESRD）治療薬の世界市場（～2026年）

Global End-Stage Renal Disease (ESRD) Drugs Market Insights and Forecast to 2026
MRC2-11QY05699 2020年11月20日 110Pages
当調査資料は末期腎疾患（ESRD）治療薬のグローバル市場について調査・分析したレポートです。種類別（コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドルマブ、その他）市場規模、用途別（病院、クリニック、ICU、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...

パーキンソン病（PD）治療薬の世界市場（～2026年）

Global Parkinson's Disease (PD) Drugs Market Insights and Forecast to 2026
MRC2-11QY08750 2020年11月25日 145Pages
当調査資料はパーキンソン病（PD）治療薬のグローバル市場について調査・分析したレポートです。種類別（ドーパミン作動薬、モノアミン酸化酵素阻害剤、アセチルコリンエステラーゼ阻害剤、グルタメート阻害剤）市場規模、用途別（病院、家族）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

薬物アレルギー治療/治療薬の世界市場（～2026年）

Global Drug Allergy Treatments and Drugs Market Insights and Forecast to 2026
MRC2-11QY05438 2020年11月20日 113Pages
当調査資料は薬物アレルギー治療/治療薬のグローバル市場について調査・分析したレポートです。種類別（ペニシリン・関連薬、サルファ剤、インスリン、ヨウ素、化学療法薬、その他）市場規模、用途別（病院、診断研究所、研究所、学術研究所、製薬・バイオテクノロジー企業）市場規模、地域別（北米、米国、カナダ、ヨーロ...

オピオイド誘発性便秘（OIC）治療薬の世界市場（～2026年）

Global Opioid Induced Constipation (OIC) Drug Market Insights and Forecast to 2026
MRC2-11QY08386 2020年11月20日 150Pages
当調査資料はオピオイド誘発性便秘（OIC）治療薬のグローバル市場について調査・分析したレポートです。種類別（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...

消化管間質腫瘍（GIST）治療薬の世界市場（～2026年）

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Insights and Forecast to 2026
MRC2-11QY06723 2020年11月20日 148Pages
当調査資料は消化管間質腫瘍（GIST）治療薬のグローバル市場について調査・分析したレポートです。種類別（アンカセルチブ、塩酸アナグレリドCR、APG-1351、ビニメチニブ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

性感染症（STD）診断の世界市場（～2026年） Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses. Sexually Transmitted Disease is growing at a faster pace owing to the rising incidences of unprotected sex, lack of a…
クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…
ベーチェット病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Behcet Disease Drug Market The global Behcet Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Behcet Disease Drug Scope and Market Size Behcet Disease Drug market is seg…
シャルコー・マリー・トゥース病IA型治療薬の世界市場（～2026年） Market Analysis and Insights: Global Charcot-Marie-Tooth Disease Type I A Drug Market The global Charcot-Marie-Tooth Disease Type I A Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Charcot-Marie-Tooth Disease Typ…
シャーガス病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chagas Disease Drug Market The global Chagas Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chagas Disease Drug Scope and Market Size Chagas Disease Drug market is seg…